A survival score for patients receiving stereotactic radiosurgery alone for brain metastases from breast cancer

Dirk Rades, Liesa Dziggel, Stefan Janssen, Oliver Blanck, Dagmar Hornung, Steven E. Schild

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aim: To generate a survival score for patients with breast cancer treated with stereotactic radiosurgery (SRS) alone for brain metastases. Patients and Methods: Seven factors were evaluated in 34 patients, namely age, performance score, number of brain metastases, maximum diameter of all brain metastases, location of brain metastases, extracerebral metastases and time between breast cancer diagnosis and SRS. The score was created from factors having a significant impact on survival. Points of 0 (worse survival) or 1 (better survival) were assigned. Factor scores were added to total prognostic scores for each patient. Results: A significant impact on survival was found for performance score (p<0.001), maximum diameter of cerebral lesions (p=0.002), and extracerebral metastases (p=0.026). Three groups were designated by score: 0-1, 2 and 3 points. One-year survival rates were 48%, 71% and 100%, respectively (p<0.001). Conclusion: This score contributes to appropriate selection of personalized treatment in patients with breast cancer with few cerebral metastases.

Original languageEnglish (US)
Pages (from-to)1073-1076
Number of pages4
JournalAnticancer Research
Volume36
Issue number3
StatePublished - Mar 1 2016

Fingerprint

Radiosurgery
Breast Neoplasms
Neoplasm Metastasis
Survival
Brain
Survival Rate

Keywords

  • Breast cancer
  • Limited number of brain metastases
  • Prognostic score
  • Stereotactic radiosurgery
  • Survival analysis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Rades, D., Dziggel, L., Janssen, S., Blanck, O., Hornung, D., & Schild, S. E. (2016). A survival score for patients receiving stereotactic radiosurgery alone for brain metastases from breast cancer. Anticancer Research, 36(3), 1073-1076.

A survival score for patients receiving stereotactic radiosurgery alone for brain metastases from breast cancer. / Rades, Dirk; Dziggel, Liesa; Janssen, Stefan; Blanck, Oliver; Hornung, Dagmar; Schild, Steven E.

In: Anticancer Research, Vol. 36, No. 3, 01.03.2016, p. 1073-1076.

Research output: Contribution to journalArticle

Rades, D, Dziggel, L, Janssen, S, Blanck, O, Hornung, D & Schild, SE 2016, 'A survival score for patients receiving stereotactic radiosurgery alone for brain metastases from breast cancer', Anticancer Research, vol. 36, no. 3, pp. 1073-1076.
Rades D, Dziggel L, Janssen S, Blanck O, Hornung D, Schild SE. A survival score for patients receiving stereotactic radiosurgery alone for brain metastases from breast cancer. Anticancer Research. 2016 Mar 1;36(3):1073-1076.
Rades, Dirk ; Dziggel, Liesa ; Janssen, Stefan ; Blanck, Oliver ; Hornung, Dagmar ; Schild, Steven E. / A survival score for patients receiving stereotactic radiosurgery alone for brain metastases from breast cancer. In: Anticancer Research. 2016 ; Vol. 36, No. 3. pp. 1073-1076.
@article{a9473d1a2c3c45a9aad2919f17cbe7c3,
title = "A survival score for patients receiving stereotactic radiosurgery alone for brain metastases from breast cancer",
abstract = "Aim: To generate a survival score for patients with breast cancer treated with stereotactic radiosurgery (SRS) alone for brain metastases. Patients and Methods: Seven factors were evaluated in 34 patients, namely age, performance score, number of brain metastases, maximum diameter of all brain metastases, location of brain metastases, extracerebral metastases and time between breast cancer diagnosis and SRS. The score was created from factors having a significant impact on survival. Points of 0 (worse survival) or 1 (better survival) were assigned. Factor scores were added to total prognostic scores for each patient. Results: A significant impact on survival was found for performance score (p<0.001), maximum diameter of cerebral lesions (p=0.002), and extracerebral metastases (p=0.026). Three groups were designated by score: 0-1, 2 and 3 points. One-year survival rates were 48{\%}, 71{\%} and 100{\%}, respectively (p<0.001). Conclusion: This score contributes to appropriate selection of personalized treatment in patients with breast cancer with few cerebral metastases.",
keywords = "Breast cancer, Limited number of brain metastases, Prognostic score, Stereotactic radiosurgery, Survival analysis",
author = "Dirk Rades and Liesa Dziggel and Stefan Janssen and Oliver Blanck and Dagmar Hornung and Schild, {Steven E.}",
year = "2016",
month = "3",
day = "1",
language = "English (US)",
volume = "36",
pages = "1073--1076",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - A survival score for patients receiving stereotactic radiosurgery alone for brain metastases from breast cancer

AU - Rades, Dirk

AU - Dziggel, Liesa

AU - Janssen, Stefan

AU - Blanck, Oliver

AU - Hornung, Dagmar

AU - Schild, Steven E.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Aim: To generate a survival score for patients with breast cancer treated with stereotactic radiosurgery (SRS) alone for brain metastases. Patients and Methods: Seven factors were evaluated in 34 patients, namely age, performance score, number of brain metastases, maximum diameter of all brain metastases, location of brain metastases, extracerebral metastases and time between breast cancer diagnosis and SRS. The score was created from factors having a significant impact on survival. Points of 0 (worse survival) or 1 (better survival) were assigned. Factor scores were added to total prognostic scores for each patient. Results: A significant impact on survival was found for performance score (p<0.001), maximum diameter of cerebral lesions (p=0.002), and extracerebral metastases (p=0.026). Three groups were designated by score: 0-1, 2 and 3 points. One-year survival rates were 48%, 71% and 100%, respectively (p<0.001). Conclusion: This score contributes to appropriate selection of personalized treatment in patients with breast cancer with few cerebral metastases.

AB - Aim: To generate a survival score for patients with breast cancer treated with stereotactic radiosurgery (SRS) alone for brain metastases. Patients and Methods: Seven factors were evaluated in 34 patients, namely age, performance score, number of brain metastases, maximum diameter of all brain metastases, location of brain metastases, extracerebral metastases and time between breast cancer diagnosis and SRS. The score was created from factors having a significant impact on survival. Points of 0 (worse survival) or 1 (better survival) were assigned. Factor scores were added to total prognostic scores for each patient. Results: A significant impact on survival was found for performance score (p<0.001), maximum diameter of cerebral lesions (p=0.002), and extracerebral metastases (p=0.026). Three groups were designated by score: 0-1, 2 and 3 points. One-year survival rates were 48%, 71% and 100%, respectively (p<0.001). Conclusion: This score contributes to appropriate selection of personalized treatment in patients with breast cancer with few cerebral metastases.

KW - Breast cancer

KW - Limited number of brain metastases

KW - Prognostic score

KW - Stereotactic radiosurgery

KW - Survival analysis

UR - http://www.scopus.com/inward/record.url?scp=84991717816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991717816&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 1073

EP - 1076

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -